Paul Sax: Bamlanivimab for COVID-19 Hard to Pronounce, Even Harder to Give

By the Editors

The monoclonal antibody bamlanivimab was recently granted an emergency use authorization to treat COVID-19 outpatients at risk for severe disease or hospitalization. Bamlanivimab is a mouthful, but administering the treatment could be even more of a challenge. Dr. Paul Sax lays out 10 gargantuan logistical hurdles in his latest HIV and ID Observations post.